Primary record
(4R,7R)-N-[(2S)-1-hydroxybutan-2-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),2,9,12(16),13-pentaene-4-carboxamide
- 库存
- 6,297 克
- 纯度
- 98.6 %
- CAS
- 113-42-8
化合物标识与属性
- CAS
- 113-42-8
- PubChem CID
- 8226
- SMILES
- CC[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C
- Canonical SMILES
- CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
名称与同义词
- methylergonovine
- Methylergometrine
- Methylergobasin
- Methylergobasine
- Methylergobrevin
- Methylergometrin
- Methylergonovin
- Methergine
- Partergin
- Basofortina
- Methergen
- Ergotyl
- Metilergometrina
- Methergin
- Methylergometrinum
- Metilergometrinio
- Ryegonovin
- Metenarin
- Methylergonovine maleate
- Spametrin-M
- Methylergometrine maleate
- Norforms
- Ergometrine, methyl-
- Metrol
- Ergotyl (TN)
- Metilergometrina [DCIT]
- ERGOTAMINE
- Methergine (TN)
- Lysergic acid butanolamide
- ERGONOVINE
- Methylergometrine (INN)
- Methylergometrine [INN:BAN]
- Spectrum_000263
- Methylergometrinum [INN-Latin]
- RefChem:55613
- Metilergometrinio [INN-Spanish]
- AC1L1QJP
- 113-42-8
- Prestwick3_000374
- Spectrum2_000613
- Spectrum3_000502
- Spectrum5_001879
- UNII-W53L6FE61V
- W53L6FE61V
- Biomol-NT_000154
- D05AHE
- HSDB 3364
- D-lysergic acid 1-butanolamide
- DTXCID303283
- D-Lysergic acid-(+)-butanolamide-(2)
- Lopac0_000794
- ME 277
- SCHEMBL78176
- BSPBio_000527
- BSPBio_002023
- CHEMBL1201356
- GTPL150
- KBioSS_000743
- METHYLERGONOVINE [MI]
- D-Lysergic acid-dl-hydroxybutylamide-2
- DivK1c_000357
- DTXSID00904978
- EINECS 204-027-0
- SPBio_000546
- METHYLERGOMETRINE [INN]
- BPBio1_000442
- BPBio1_000581
- C20H25N3O2
- METHYLERGOMETRINE [HSDB]
- METHYLERGONOVINE [VANDF]
- DTXSID1023283
- SCHEMBL29368336
- CHEBI:92607
- KBio1_000357
- KBio2_000743
- KBio2_003311
- KBio2_005879
- KBio3_001523
- CID8226
- G02AB01
- N-(alpha-(Hydroxymethyl)propyl)-D-lysergamide
- NINDS_000357
- UNBRKDKAWYKMIV-QWQRMKEZSA-N
- METHYLERGOMETRINE [WHO-DD]
- Tox21_110809
- BDBM50330860
- EBC-26652
- ME-277
- NCGC00017258-04
- ZINC95619105
- C20-H25-N3-O2
- Tox21_110809_1
- CCG-204878
- DB00353
- J5.132B
- SDCCGSBI-0050771.P005
- IDI1_000357
- Lysergamide, N-((S)-1-(hydroxymethyl)propyl)-
- NCGC00017258-03
- NCGC00017258-05
- NCGC00017258-06
- NCGC00017258-08
- NCGC00017258-12
- NCGC00024646-02
- NCGC00024646-03
- CAS-113-42-8
- DA-75495
- LS-64363
- SBI-0050771.P004
- AB00514664
- CS-0647098
- NS00023683
- (6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
- N-[alpha-(Hydroxymethyl)propyl]-D-lysergamide
- D08207
- AB00053497_03
- EN300-6481358
- 191038-EP2275420A1
- 191038-EP2280008A2
- Q424477
- 9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-6-methylergoline-8-carboxamide
- ERGOMETRINE MALEATE IMPURITY D [EP IMPURITY]
- 9,10-Didehydro-N-(alpha-(hydroxymethyl)propyl)-6-methyl-ergoline-8-beta-carboxamide
- BRD-K34685430-001-01-1
- BRD-K34685430-050-04-2
- BRD-K34685430-050-06-7
- BRD-K34685430-050-11-7
- BRD-K34685430-050-12-5
- (8beta)-N-[(2S)-1-hydroxybutan-2-yl]-6-methyl-9,10-didehydroergoline-8-carboxamide
- 9,10-Didehydro-N-(1-(hydroxymethyl)-propyl)-D-lysergamide
- 9,10-Didehydro-N-[1-(hydroxymethyl)-propyl]-D-lysergamide
- Ergoline-8-beta-carboxamide, 9,10-didehydro-N-((S)-1-(hydroxymethyl)propyl)-6-methyl-
- Ergoline-8-carboxamide, 9,10-didehydro-N-(1-(hydroxymethyl)propyl)-6-methyl-, (8beta(S))-
- (8beta)-N-[(1S)-1-(hydroxymethyl)propyl]-6-methyl-9,10-didehydroergoline-8-carboxamide
- (8-beta)-9,10-Didehydro-N-[(1S)-1-(hydroxymethyl)propyl]-6-methylergoline-8-carboxamide
- (8|A)-9,10-Didehydro-N-[(1S)-1-(hydroxymethyl)propyl]-6-methylergoline-8-carboxamide
- 9,10-Didehydo-N-[(S)-1-(hydroxymethyl)propyl]-6-methylergoline-8beta-carboxamide
- 9,10-Didehydro-N-[(S)-1-(hydroxymethyl)propyl]-6-methylergoline-8beta-carboxamide
- N-[(2S)-1-Hydroxybutan-2-yl]-6-methyl-9,10-didehydroergoline-8beta-carboxamide
- (4R,7R)-N-((2S)-1-hydroxybutan-2-yl)-6-methyl-6,11-diazatetracyclo(7.6.1.0^(2,7).0^(12,16))hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
- (4R,7R)-N-((2S)-1-hydroxybutan-2-yl)-6-methyl-6,11-diazatetracyclo(7.6.1.02,7.012,16)hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
- (4R,7R)-N-[(2S)-1-hydroxybutan-2-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),2,9,12(16),13-pentaene-4-carboxamide
- (4R,7R)-N-[(2S)-1-hydroxybutan-2-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
- (4R,7R)-N-[(2S)-1-hydroxybutan-2-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
- (6aR,9R)-N-((2S)-1-hydroxybutan-2-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo(4,3-fg)quinoline-9-carboxamide
- (6aR,9R)-N-((S)-1-hydroxybutan-2-yl)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
- (8.BETA.)-N-((1S)-1-(HYDROXYMETHYL)PROPYL)-6-METHYL-9,10-DIDEHYDROERGOLINE-8-CARBOXAMIDE
- 204-027-0
- Ergoline-8-carboxamide, 9,10-didehydro-N-[1-(hydroxymethyl)propyl]-6-methyl-, [8.beta.(S)]-
- H8D